Cargando...
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
Ewing sarcoma is the second most common solid bone malignancy diagnosed in pediatric and young adolescent populations. Despite global co-operative efforts, outcomes for patients with relapsed and refractory disease remains obstinately poor. It has become increasingly clear that disruption of the epi...
Gardado en:
| Publicado en: | Oncotarget |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Impact Journals LLC
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6284858/ https://ncbi.nlm.nih.gov/pubmed/30559927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26326 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|